Showing results (51-60 of 58) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
NPJ Vaccines|June 19, 2024
Mucosal bivalent live attenuated vaccine protects against human metapneumovirus and respiratory syncytial virus in miceDaniela Ogonczyk-Makowska, Pauline Brun, Clémence Vacher, et al.Antiviral Research|March 22, 2020
Labyrinthopeptins as virolytic inhibitors of respiratory syncytial virus cell entrySebastian Blockus, Svenja M Sake, Martin Wetzke, et al.Journal of Virology|October 31, 2014
Interactome analysis of the human respiratory syncytial virus RNA polymerase complex identifies protein chaperones as important cofactors that promote L-protein stability and RNA synthesisDiane C Munday, Weining Wu, Nikki Smith, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 11, 2022
Macromolecular Viral Entry Inhibitors as Broad-Spectrum First-Line Antivirals with Activity against SARS-CoV-2Rüdiger Groß, Lívia Mesquita Dias Loiola, Leila Issmail, et al.Nature Materials|December 19, 2017
Broad-spectrum non-toxic antiviral nanoparticles with a virucidal inhibition mechanismValeria Cagno, Patrizia Andreozzi, Marco D'Alicarnasso, et al.Nature|January 28, 2026
Pre-assembly of biomolecular condensate seeds drives RSV replicationDhanushika Ratnayake, Marie Galloux, Sanne Boersma, et al.Science (New York, N.Y.)|May 16, 2020
De novo protein design enables the precise induction of RSV-neutralizing antibodiesFabian Sesterhenn, Che Yang, Jaume Bonet, et al.Nature Communications|February 8, 2024
Drug repurposing screen identifies lonafarnib as respiratory syncytial virus fusion protein inhibitorSvenja M Sake, Xiaoyu Zhang, Manoj Kumar Rajak, et al.Pageof 6